Insider holders · CIK 0000315545
PROVECTUS BIOPHARMACEUTICALS, INC. · PVCT
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Eric Wachter Ph.D.Chief Technology Officer | 5,714,183 | 4,867 | 5,719,050 | Mar 31, 2016 · 7:34 pm EDT | Form 4 |
| Edward PershingDirector | 2,820,630 | 550,000 | 3,370,630 | May 7, 2018 · 5:47 pm EDT | Form 3 |
| Peter R Culpepperrelationship not stated | 1,411,829 | 296,503 | 1,708,332 | Jan 9, 2017 · 8:55 pm EST | Form 4 |
| Timothy Scott Ph.D.President | 1,521,845 | 55,996 | 1,577,841 | Jan 7, 2015 · 3:28 pm EST | Form 4 |
| Bruce HorowitzDirector | 1,392,243 | 50,000 | 1,442,243 | Apr 13, 2017 · 5:17 pm EDT | Form 3 |
| Dominic RodriguesDirector | 940,989 | 242,000 | 1,182,989 | Apr 13, 2017 · 5:15 pm EDT | Form 3 |
| Jan KoeDirector | 786,300 | 150,000 | 936,300 | Mar 31, 2016 · 7:31 pm EDT | Form 4 |
| John R GlassSee Remarks | 200,000 | — | 200,000 | Dec 18, 2017 · 12:20 pm EST | Form 4 |
| John Lacy IIIDirector | 100,000 | — | 100,000 | May 7, 2018 · 7:11 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.